Skip to content Larimar Therapeutics
Larimar Therapeutics Mobile Menu Toggle navigation
Larimar Therapeutics
  • About Larimar
    • Company Overview
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Careers
  • Our Science
    • Scientific Approach
    • Publications
  • Our Programs
    • Pipeline
    • Nomlabofusp
    • Expanded Access Policy
  • Our Partners
  • Investors
    • Investors
    • Press Releases
    • Events & Presentations
    • Corporate Governance
    • Financials & Filings
    • Stock Information
    • Analyst Coverage
    • Investor FAQS
    • Contact Us
    • Email Alerts
  • News
  • Contact
    • Contact Us
    • Directions
  • About Larimar
    • Company Overview
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Careers
  • Our Science
    • Scientific Approach
    • Publications
  • Our Programs
    • Pipeline
    • Nomlabofusp
    • Expanded Access Policy
  • Our Partners
  • Investors
    • Investors
    • Press Releases
    • Events & Presentations
    • Corporate Governance
    • Financials & Filings
    • Stock Information
    • Analyst Coverage
    • Investor FAQS
    • Contact Us
    • Email Alerts
  • News
  • Contact
    • Contact Us
    • Directions

Board of Directors

Carole Ben-Maimon, MD

Carole Ben-Maimon, MD >

Chief Executive Officer

Joseph Truitt

Joseph Truitt >

BOARD CHAIR

Tom Hamilton

Tom Hamilton >

Jonathan Leff

Jonathan Leff >

Frank E. Thomas

Frank E. Thomas >

Jeffrey Sherman, MD

Jeffrey Sherman, MD >

© 2026 Larimar Therapeutics, Inc. All rights reserved.
LARIMAR and LARIMAR THERAPEUTICS are trademarks of Larimar Therapeutics, Inc.

  • Terms of Use
  • Privacy Policy
  • Site Credits